BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38916730)

  • 21. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.
    Komuro Y; Xu G; Bhaskar K; Lamb BT
    Neurobiol Aging; 2015 Jun; 36(6):2034-42. PubMed ID: 25863528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy.
    Mazzaro N; Barini E; Spillantini MG; Goedert M; Medini P; Gasparini L
    J Neurosci; 2016 Feb; 36(7):2086-100. PubMed ID: 26888921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline.
    Wang L; Liu M; Gao J; Smith AM; Fujioka H; Liang J; Perry G; Wang X
    J Alzheimers Dis; 2021; 84(3):1057-1069. PubMed ID: 34602490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377.
    Xu GB; Guan PP; Wang P
    Mol Neurobiol; 2021 Mar; 58(3):1114-1127. PubMed ID: 33095414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy.
    Rossi F; Geiszler PC; Meng W; Barron MR; Prior M; Herd-Smith A; Loreto A; Lopez MY; Faas H; Pardon MC; Conforti L
    Behav Brain Res; 2018 Feb; 339():140-152. PubMed ID: 29175372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer's disease and other tauopathies.
    Abey A; Davies D; Goldsbury C; Buckland M; Valenzuela M; Duncan T
    Brain Pathol; 2021 Jan; 31(1):144-162. PubMed ID: 32810333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromogranin A (CgA) Deficiency Attenuates Tauopathy by Altering Epinephrine-Alpha-Adrenergic Receptor Signaling.
    Jati S; Munoz-Mayorga D; Shahabi S; Tang K; Tao Y; Dickson DW; Litvan I; Ghosh G; Mahata SK; Chen X
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology.
    Maphis NM; Jiang S; Binder J; Wright C; Gopalan B; Lamb BT; Bhaskar K
    Front Mol Neurosci; 2017; 10():69. PubMed ID: 28367114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
    Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K
    Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation.
    Yang YY; Ren YT; Jia MY; Bai CY; Liang XT; Gao HL; Zhong ML; Wang T; Guo C
    Exp Neurol; 2023 Apr; 362():114346. PubMed ID: 36750170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling.
    Shu X; Zhang Y; Li M; Huang X; Yang Y; Zeng J; Zhao Y; Wang X; Zhang W; Ying Y
    Neuropharmacology; 2019 Jul; 153():1-12. PubMed ID: 31015047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.
    Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H
    J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy.
    Trease AJ; George JW; Roland NJ; Lichter EZ; Emanuel K; Totusek S; Fox HS; Stauch KL
    Front Mol Neurosci; 2022; 15():852368. PubMed ID: 35359570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
    Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH
    J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APPsα Rescues Tau-Induced Synaptic Pathology.
    Bold CS; Baltissen D; Ludewig S; Back MK; Just J; Kilian L; Erdinger S; Banicevic M; Rehra L; Almouhanna F; Nigri M; Wolfer DP; Spilger R; Rohr K; Kann O; Buchholz CJ; von Engelhardt J; Korte M; Müller UC
    J Neurosci; 2022 Jul; 42(29):5782-5802. PubMed ID: 35667850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease.
    He Z; Zhang H; Li X; Tu S; Wang Z; Han S; Du X; Shen L; Li N; Liu Q
    Phytomedicine; 2023 Jan; 109():154555. PubMed ID: 36610160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
    Liu M; Wang L; Gao J; Dong Q; Perry G; Ma X; Wang X
    J Alzheimers Dis; 2019; 69(4):1077-1087. PubMed ID: 31156179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.